Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

60 Degrees Pharmaceuticals (SXTPW) Shares Outstanding (Weighted Average) (2022 - 2025)

Historic Shares Outstanding (Weighted Average) for 60 Degrees Pharmaceuticals (SXTPW) over the last 4 years, with Q3 2025 value amounting to $3.7 million.

  • 60 Degrees Pharmaceuticals' Shares Outstanding (Weighted Average) rose 65214.92% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year increase of 65214.92%. This contributed to the annual value of $454582.0 for FY2024, which is 58549.93% up from last year.
  • 60 Degrees Pharmaceuticals' Shares Outstanding (Weighted Average) amounted to $3.7 million in Q3 2025, which was up 65214.92% from $1.5 million recorded in Q2 2025.
  • In the past 5 years, 60 Degrees Pharmaceuticals' Shares Outstanding (Weighted Average) registered a high of $3.7 million during Q3 2025, and its lowest value of $66314.0 during Q4 2023.
  • Its 4-year average for Shares Outstanding (Weighted Average) is $1.3 million, with a median of $886058.0 in 2024.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first tumbled by 9719.93% in 2023, then soared by 66054.3% in 2025.
  • 60 Degrees Pharmaceuticals' Shares Outstanding (Weighted Average) (Quarter) stood at $2.4 million in 2022, then tumbled by 97.2% to $66314.0 in 2023, then surged by 585.5% to $454582.0 in 2024, then soared by 708.52% to $3.7 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $3.7 million for Q3 2025, versus $1.5 million for Q2 2025 and $1.3 million for Q1 2025.